Mespiros, Eva .
HRN: 15-51-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2022
CEFUROXIME 500MG (TAB)
07/05/2022
07/09/2022
ORAL
500mg
BID
S/P TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes